EUVIMEDPoznaj EUVIMED
Crossref

Has Sex‐Based Disparity in Liver Transplantation Opportunities and Waitlist Mortality Improved in the MELD3.0 Era?: A Preliminary Study

Miho Akabane, Yuki Imaoka, Carlos O Esquivel, Kazunari Sasaki

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70064 ↗

At a glance

Journal article in Clinical Transplantation, 2025. Written by Miho Akabane and 3 co-authors. Institution: Division of Abdominal Transplant, Department of Surgery, Stanford University Medical Center, Stanford, California, USA. Major MEDLINE topics: Liver Transplantation, Waiting Lists, End Stage Liver Disease, Healthcare Disparities. Cited 12 times so far (Crossref); 15 references. Funded by: Mitsukoshi Health and Welfare Foundation.

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Background

In July 2023, the OPTN adopted MELD3.0 to address sex‐based disparities in liver transplantation (LT) opportunity and waitlist mortality. No studies have proven that MELD3.0 alleviated them.

Methods

We evaluated sex‐based disparities in LT opportunities and waitlist mortality, utilizing the UNOS data (August 2022–March 2024), comparing pre‐ and post‐MELD3.0 eras.

Results

Among 11 795 LT candidates (pre‐MELD3.0: 7263; post‐MELD3.0: 4532), the proportion of females increased from 38.8% to 42.6% post‐MELD3.0. In the transplanted population, females increased from 37.7% to 41.6% post‐MELD3.0. The median MELD score difference (“MELD3.0–MELD‐Na”) at listing was ‐0.26 [‐2.13, 0.80] for females and ‐0.86 [‐2.92, 0.00] for males ( p < 0.01). Compared to females, males consistently showed a larger drop in points from MELD‐Na to MELD3.0. In the pre‐MELD3.0 era, females had lower LT opportunity (sub‐hazard ratio [sHR]: 0.88 [0.83–0.93], p < 0.01) and higher waitlist mortality (sHR: 1.39 [1.20–1.62], p < 0.01). In the post‐MELD3.0 era, there were no significant differences in LT opportunity (sHR: 0.93 [0.87–1.00], p = 0.07) and waitlist mortality (sHR: 1.25 [0.98–1.57], p = 0.26). Subgroup analyses based on MELD‐Na groups showed that significant differences in LT opportunity and waitlist mortality in the pre‐MELD3.0 era became insignificant in the post‐MELD3.0 era. Multivariable competing‐risk analysis showed that, in the pre‐MELD3.0 era, female sex was a significant risk factor for LT opportunity (sHR: 0.90 [0.84–0.96], p < 0.01) and waitlist mortality (sHR: 1.19 [1.01–1.38], p = 0.03), but in the post‐MELD3.0 era, it was not significant (sHR: 0.94 [0.86–1.02], p = 0.11 for LT opportunity/sHR: 1.08 [0.83–1.40], p = 0.57 for waitlist mortality).

Conclusions

Our preliminary findings suggest that MELD3.0 has the potential to reduce sex‐based disparities in LT opportunities and waitlist mortality.

Subjects

MeSH terms (MEDLINE)

Liver TransplantationWaiting ListsEnd Stage Liver DiseaseHealthcare DisparitiesHumansFemaleMaleMiddle AgedFollow-Up StudiesPrognosisSurvival RateSex FactorsRisk FactorsAdultSeverity of Illness IndexTissue and Organ Procurement

Author keywords

Model for End‐Stage Liver Disease (MELD)3.0liver transplantation (LT)sexthe United Network for Organ Sharing (UNOS)

Authors and institutions

  • Division of Abdominal Transplant, Department of Surgery, Stanford University Medical Center, Stanford, California, USA.

Funding

  • Mitsukoshi Health and Welfare Foundation

Cite

APA

Akabane, M., Imaoka, Y., Esquivel, C. O., & Sasaki, K. (2025). Has Sex‐Based Disparity in Liver Transplantation Opportunities and Waitlist Mortality Improved in the MELD3.0 Era?: A Preliminary Study. Clinical Transplantation. https://doi.org/10.1111/ctr.70064

Vancouver

Akabane M, Imaoka Y, Esquivel CO, Sasaki K. Has Sex‐Based Disparity in Liver Transplantation Opportunities and Waitlist Mortality Improved in the MELD3.0 Era?: A Preliminary Study. Clinical Transplantation. 2025. doi:10.1111/ctr.70064

BibTeX
@article{Akabane2025,
  author = {Akabane, Miho and Imaoka, Yuki and Esquivel, Carlos O and Sasaki, Kazunari},
  title = {Has Sex‐Based Disparity in Liver Transplantation Opportunities and Waitlist Mortality Improved in the MELD3.0 Era?: A Preliminary Study},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70064}
}
Start for free →